Biblio Discovery — Demo Discovery Service

3 hasil untuk "Nalini Devi Verusingam"

Menampilkan 1–3 · 3,96 detik · RSS

  1. Artikel Jurnal Teks lengkap

    RNA therapeutic targeting of recalcitrant and rare cancers

    Afeez Adekunle Ishola; Nalini Devi Verusingam; Bashir Lawal

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    In 2013, more than a decade ago, the “Recalcitrant Cancer Research Act of 2012” was signed into law in the USA. Recalcitrant cancers are among the leading causes of global cancer morbidity and mortality. At the inception of the act, priority was placed on lungs and pancreatic cancers. Despite the…

  2. Artikel Jurnal Teks lengkap

    Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming

    Nalini Devi Verusingam; Swee Keong Yeap; Huynh Ky dkk.

    PeerJ, Vol. 5 · 2017 · Inggris · DOAJ Scopus

    Although numbers of cancer cell lines have been shown to be successfully reprogrammed into induced pluripotent stem cells (iPSCs), reprogramming Oral Squamous Cell Carcinoma (OSCC) to pluripotency in relation to its cancer cell type and the expression pattern of pluripotent genes under later…

  3. Artikel Jurnal

    CircSPINT2 confers sensitivity to osimertinib via hsa-miR-1296-3p/RBP1 axis and inhibits NSCLC progression

    Nalini Devi Verusingam; Aliaksandr A. Yarmishyn; Min-Long Tsai dkk.

    Molecular Therapy: Oncology, Vol. 33 No. 3 · 2025 · Inggris · DOAJ Scopus

    Lung adenocarcinoma (LUAD) is the most common type of lung cancer. Prolonged treatment of LUAD with 1st/2nd generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) promotes the emergence of secondary EGFR T790M mutation conferring resistance to these drugs. Patients who…